Ultrasound-programmable tumor extracellular vesicles delivery system for dual immune–epigenetic therapy against colorectal cancer metastasis
Authors:
- 18 June 2026
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 397, 115114
Abstract
No abstract availableKeywords
Funding Information
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
This publication has 51 references indexed in Scilit:
- Chinese Expert Consensus on the Use of Ultrasound‐Derived Fat Fraction in the Assessment of Metabolic Dysfunction‐Associated Steatotic Liver Disease (2025 Edition)Portal Hypertension & Cirrhosis, 2026
- Deep Learning‐Based Prediction of High‐Risk Gastroesophageal Varices Using Two‐Dimensional Shear Wave ElastographyPortal Hypertension & Cirrhosis, 2025
- Glucose restriction shapes pre-metastatic innate immune landscapes in the lung through exosomal TRAILCell, 2025
- Chemokines and the immune response to cancerImmunity, 2021
- Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosisJournal of Controlled Release, 2017
- Mechanisms of RNA loading into exosomesFEBS Letters, 2015
- Dynamics of exosome internalization and traffickingJournal of Cellular Physiology, 2012
- Microbubbles in ultrasound-triggered drug and gene deliveryAdvanced Drug Delivery Reviews, 2008
- Dynasore, a Cell-Permeable Inhibitor of DynaminDevelopmental Cell, 2006
- Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3Nature, 2001